Last reviewed · How we verify
US Sourced Avastin® — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
US Sourced Avastin® (US Sourced Avastin®) — Cipla BioTec Pvt. Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| US Sourced Avastin® TARGET | US Sourced Avastin® | Cipla BioTec Pvt. Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- US Sourced Avastin® CI watch — RSS
- US Sourced Avastin® CI watch — Atom
- US Sourced Avastin® CI watch — JSON
- US Sourced Avastin® alone — RSS
Cite this brief
Drug Landscape (2026). US Sourced Avastin® — Competitive Intelligence Brief. https://druglandscape.com/ci/us-sourced-avastin. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab